Norepinephrine and serotonin transporter genes: Impact on treatment response in depression

Neuropsychobiology

Volumn 62, Issue 2, 2010, Pages 121-131

  Baffa, Anna ^a   Hohoff, Christa ^a   Baune, Bernhard T ^a,d   Müller Tidow, Carsten ^a   Tidow, Nicola ^a   Freitag, Christine ^b   Zwanzger, Peter ^a   Deckert, Jürgen ^c   Arolt, Volker ^a   Domschke, Katharina ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d JAMES COOK UNIVERSITY   (Australia)

Author keywords

Antidepressants; Anxious depression; Norepinephrine transporter; Pharmacogenetics; Serotonin transporter

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; MIRTAZAPINE; NORADRENALIN TRANSPORTER; SEROTONIN TRANSPORTER; VENLAFAXINE;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROMOTER REGION; TREATMENT RESPONSE; ADULT; ANALYSIS OF VARIANCE; CAUCASIAN; DEPRESSIVE DISORDER, MAJOR; FOLLOW UP; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHARMACOGENETICS; PROCEDURES; PSYCHOLOGICAL RATING SCALE; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DNA MUTATIONAL ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PHARMACOGENETICS; POLYMORPHISM, GENETIC; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TREATMENT OUTCOME;

EID: 77953929153     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000317285     Document Type: Article

References (42)

1. Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK: Cross-national epidemiology of major depression and bipolar disorder. JAMA 1996; 276: 293-299.
2. Weissman MM, Bland R, Joyce PR, Newman S, Wells JE, Wittchen HU: Sex differences in rates of depression: cross-national perspectives. J Affect Disord 1993; 29: 77-84.
3. Kendler KS, Gatz M, Gardner CO, Pedersen NL: A Swedish national twin study of lifetime major depression. Am J Psychiatry 2006; 163: 109-114.
4. Sullivan PF, Neale MC, Kendler KS: Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 2000; 157: 1552-1562.
5. Schloss P, Williams DC: The serotonin transporter: a primary target for antidepressant drugs. J Psychopharmacol 1998; 2: 115-121.
6. Serretti A, Kato M, de Ronchi D, Kinoshita T: Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with selective serotonin reuptake inhibitor efficacy in depressed patients. Mol Psychiatry 2007; 12: 247-257.
7. Hu XZ, Rush AJ, Charney D, Wilson AF, Sorant AJ, Papanicolaou GJ, Fava M, Trivedi MH, Wisniewski SR, Laje G, Paddock S, Mc-Mahon FJ, Manji H, Lipsky RH: Association between a functional serotonin transporter promoter polymorphism and citalopram treatment in adult outpatients with major depression. Arch Gen Psychiatry 2007; 64: 783-792.
8. Pörzgen P, Bönisch H, Brüss M: Molecular cloning and organization of the coding region of the human norepinephrine transporter gene. Biochem Biophys Res Commun 1996; 227: 642-643.
9. Giros B, Wang YM, Suter S, McLeskey SB, Pifl C, Caron MG: Delineation of discrete domains for substrate, cocaine, and tricyclic antidepressant interactions using chimeric dopamine-norepinephrine transporters. J Biol Chem 1994; 269: 15985-15988.
10. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR: Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 1992; 14: 1104-1106.
11. Lesch KP, Wolozin BL, Estler HC, Murphy DL, Riederer P: Isolation of a cDNA encoding the human brain serotonin transporter. J Neural Transm Gen Sect 1993; 91: 67-72.
12. Ramamoorthy S, Bauman AL, Moore KR, Han H, Yang-Feng T, Chang AS, Ganapathy V, Blakely RD: Antidepressant- and cocainesensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization. Proc Natl Acad Sci USA 1993; 90: 2542-2546.
13. Owen D, Du L, Bakish D, Lapierre YD, Hrdina PD: Norepinephrine transporter gene polymorphism is not associated with susceptibility to major depression. Psychiatry Res 1999; 87: 1-5.
14. Zill P, Engel R, Baghai TC, Juckel G, Frodl T, Müller-Siecheneder F, Zwanzger P, Schüle C, Minov C, Behrens S, Rupprecht R, Hegerl U, Möller HJ, Bondy B: Identification of a naturally occurring polymorphism in the promoter region of the norepinephrine transporter and analysis in major depression. Neuropsychopharmacology 2002; 26: 489-493.
15. Chang CC, Lu RB, Chen CL, Chu CM, Chang HA, Huang CC, Huang YL, Huang SY: Lack of association between the norepinephrine transporter gene and major depression in a Han Chinese population. J Psychiatry Neurosci 2007; 32: 121-128.
16. Inoue K, Itoh K, Yoshida K, Shimizu T, Suzuki T: Positive association between T-182C polymorphism in the norepinephrine transporter gene and susceptibility to major depressive disorder in a Japanese population. Neuropsychobiology 2004; 50: 301-304.
17. Ryu SH, Lee SH, Lee HJ, Cha JH, Ham BJ, Han CS, Choi MJ, Lee MS: Association between norepinephrine transporter gene polymorphism and major depression. Neuropsychobiology 2004; 49: 174-177.
18. Yoshida K, Takahashi H, Higuchi H, Kamata M, Ito K, Sato K, Naito S, Shimizu T, Itoh K, Inoue K, Suzuki T, Nemeroff CB: Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms. Am J Psychiatry 2004; 161: 1575-1580.
19. Willeit M, Praschak-Rieder N, Neumeister A, Zill P, Leisch F, Stastny J, Hilger E, Thierry N, Konstantinidis A, Winkler D, Fuchs K, Sieghart W, Aschauer H, Ackenheil M, Bondy B, Kasper S: A polymorphism (5- HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder. Mol Psychiatry 2003; 8: 942-946.
20. Serretti A, Mandelli L, Lorenzi C, Pirovano A, Olgiati P, Colombo C, Smeraldi E: Serotonin transporter gene influences the time course of improvement of core depressive and somatic anxiety symptoms during treatment with SSRIs for recurrent mood disorders. Psychiatry Res 2007; 149: 185-193.
21. Baune BT, Hohoff C, Roehrs T, Deckert J, Arolt V, Domschke K: Serotonin receptor 1A-1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression? Neurosci Lett 2008; 436: 111-115.
22. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH: Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR * D report. Am J Psychiatry 2008; 165: 342-351.
23. Domschke K, Deckert J, Arolt V, Baune B: Anxious versus non-anxious depression: difference in treatment outcome. J Psychopharmacol 2008, E-pub ahead of print.
24. Baune BT, Hohoff C, Berger K, Neumann A, Mortensen S, Roehrs T, Deckert J, Arolt V, Domschke K: Association of the COMT val- 158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology 2008; 33: 924-932.
25. Domschke K, Hohoff C, Mortensen LS, Roehrs T, Deckert J, Arolt V, Baune BT: Monoamine oxidase A variant influences antidepressant treatment response in female patients with major depression. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 224-228.
26. Kim CH, Hahn MK, Joung Y, Anderson SL, Steele AH, Mazei-Robinson MS, Gizer I, Teicher MH, Cohen BM, Robertson D, Waldman ID, Blakely RD, Kim KS: A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc Natl Acad Sci USA 2006; 103: 19164-19169.
27. Lee YJ, Hohoff C, Domschke K, Sand P, Kuhlenbäumer G, Schirmacher A, Freitag CM, Meyer J, Stöber G, Franke P, Nöthen MM, Fritze J, Fimmers R, Garritsen HS, Stögbauer F, Deckert J: Norepinephrine transporter (NET) promoter and 5 -UTR polymorphisms: association analysis in panic disorder. Neurosci Lett 2005; 377: 40-43.
28. Dlugos A, Freitag C, Hohoff C, McDonald J, Cook EH, Deckert J, de Wit H: Norepinephrine transporter gene variation modulates acute response to D-amphetamine. Biol Psychiatry 2007; 61: 1296-1305.
29. Deckert J, Catalano M, Heils A, di Bella D, Friess F, Politi E, Franke P, Nöthen MM, Maier W, Bellodi L, Lesch KP: Functional promoter polymorphism of the human serotonin transporter: lack of association with panic disorder. Psychiatr Genet 1997; 7: 45-47.
30. Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL: Simultaneous genotyping of four functional loci of human SLC6A4, with a reappraisal of 5-HTTLPR and rs25531. Mol Psychiatry 2006; 11: 224-226.
31. Baune BT, Hohoff C, Mortensen LS, Deckert J, Arolt V, Domschke K: Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: a female specific effect? Depress Anxiety 2007; 25: 920-925.
32. Stephens M, Donnelly P: A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-1169.
33. Kim H, Lim SW, Kim S, Kim JW, Chang YH, Carroll BJ, Kim DK: Monoamine transporter gene polymorphisms and antidepressant response in Koreans with late-life depression. JAMA 2006; 296: 1609-1618.
34. Owens MJ, Krulewicz S, Simon JS, Sheehan DV, Thase ME, Carpenter DJ, Plott SJ, Nemeroff CB: Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine. Neuropsychopharmacology 2008; 33: 3201-3212.
35. Debonnel G, Saint-André E, Hébert C, de Montigny C, Lavoie N, Blier P: Differential physiological effects of a low dose and high doses of venlafaxine in major depression. Int J Neuropsychopharmacol 2007; 10: 51-61.
36. Domschke K, Deckert J, ODonovan MC, Glatt SJ: Meta-analysis of COMT val158met in panic disorder: ethnic heterogeneity and gender specificity. Am J Med Genet B Neuropsychiatr Genet 2007; 144B:667-673.
37. Yang SP, Pau KY, Spies HG: Gonadectomy alters tyrosine hydroxylase and norepinephrine transporter mRNA levels in the locus coeruleus in rabbits. J Neuroendocrinol 1997; 9: 763-768.
38. McMahon FJ, Buervenich S, Charney D, Lipsky R, Rush AJ, Wilson AF, Sorant AJ, Papanicolaou GJ, Laje G, Fava M, Trivedi MH, Wisniewski SR, Manji H: Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. Am J Hum Genet 2006; 78: 804-814.
39. Bagby RM, Ryder AG, Cristi C: Psychosocial and clinical predictors of response to pharmacotherapy for depression. J Psychiatry Neurosci 2002; 27: 250-257.
40. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Müller CR, Hamer DH, Murphy DL: Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996; 274: 1527-1531.
41. Stein MB, Seedat S, Gelernter J: Serotonin transporter gene promoter polymorphism predicts SSRI response in generalized social anxiety disorder. Psychopharmacology (Berl) 2006; 187: 68-72.
42. Perna G, Favaron E, di Bella D, Bussi R, Bellodi L: Antipanic efficacy of paroxetine and polymorphism within the promoter of the serotonin transporter gene. Neuropsychopharmacol 2005; 30: 2230-2235.